Insulin resistance in women with polycystic ovary syndrome: Relationship with anthropometric and biochemical variables;Resistência à insulina em mulheres com síndrome dos ovários policísticos: Relação com as variáveis antropométricas e bioquímicas

Revista Brasileira de Ginecologia e Obstetricia

Volumn 34, Issue 2, 2012, Pages 74-79

  Pontes, Ana Gabriela ^a   Rehme, Marta Francis Benevides ^b   Martins, Anice Maria Vieira de Camargo ^a   Micussi, Maria Thereza Albuquerque Barbosa Cabral ^c   Maranhão, Técia Maria de Oliveira ^c   Pimenta, Walkyria de Paula ^a   Pontes, Anaglória ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Body mass index; Insulin resistance; Obesity; Polycystic ovary syndrome

Indexed keywords

ADULT; ARTICLE; BLOOD; BODY MASS; FEMALE; HUMAN; INSULIN RESISTANCE; METABOLISM; OVARY POLYCYSTIC DISEASE; RETROSPECTIVE STUDY; WAIST CIRCUMFERENCE;

BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84859114975     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032012000200006     Document Type: Article

References (38)

1. Whitaker KN. Polycystic ovary syndrome: an overview. J Pharm Pract. 2011;24(1):94-101.
2. Teede HJ, Stuckey BG. Polycystic ovary syndrome and abnormal glucose tolerance. Med J Aust. 2007;187(6):324-5.
3. Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am. 2005;34(3):677-705.
4. Traub ML. Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes. 2011;2(3):33-40.
5. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50(1):113-6.
6. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2004;82(3):661-5.
7. DeUgarte CM, Bartollucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454-60.
8. Martins WP, Santana LF, Nastri CO, Ferriani RA, Sá MFS, Reis RM. Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women. Eur J Obstet Gynecol Reprod Biol. 2007;133(2):203-7.
9. Dunaif A, Segal KR, Futterweit W, Dobrjannsky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165-74.
10. Tfayli H, Arslanian S. Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon. Arq Bras Endocrinol Metab. 2009;53(2):165-74.
11. Pauli JM, Raja-Khan N, Wu X, Legro RS. Current perspectives of insulin resistance and polycystic ovary syndrome. Diabet Med. 2011;28(12):1445-54.
12. Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(8):3626-31.
13. Hayashida SAY, Halbe HW, Marcondes JAM, Nomando APC, Lopes CMC, Gonçalves MA, et al. Comparação entre diferentes índices de avaliação da sensibilidade à insulina na síndrome dos ovários policísticos. Rev Ginecol Obstet. 2004;15(2):69-77.
14. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvien H, Van Haeften T, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23(3):295-301.
15. Manucci E, Bardini G, Rotella F, Rotella CM. Comparison among different insulin sensitivity indices in obese patients. Diabet Med. 2003;20(6):462-6.
16. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care.1999;22(9):1462-70.
17. Rotterdam ESHRE/ASRM-Sponsored PCOS. Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19(1):41-7.
18. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815-30.
19. Hermmans-Le T, Hermanns JF, Piérard GE. Juvenile acanthosis nigricans and insulin resistance. Pediatr Dermatol. 2002;19(1):12-4.
20. Rosenfield RL, Lucky AW. Acne, hirsutism, and alopecia in adolescents girls. Clinical expressions of androgen excess. Endocrinol Metab Clin North Am. 1993;22(3):507-32.
21. Hans TS, Van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311(7017):1401-5.
22. World Health Organization. Obesity preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO; 1997.
23. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88(5 Pt 1):2460-70.
24. Sociedade Brasileira de Cardiologia. IV diretriz brasileira sobre dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol. 2007;88(Suppl 1):1-18.
25. Matthews D, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28(7):412-9.
26. Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN. The threshold value for insulin resistance (HOMA-IR) in an admixture population IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract. 2006;72(2):219-20.
27. Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a populationbased comparison. BMC Cardiovasc Disord. 2005;5:26.
28. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006;113(10):1210-7.
29. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347-63.
30. Vieira CS, Gomes MKO, Rodrigues PC, Pinto APM, Reis RM, Ferriani RA, et al. Avaliação da função das células β-pancreáticas através do modelo matemático de HOMA em portadoras de síndrome dos ovários policísticos: comparação entre obesas e não-obesas. Rev Bras Ginecol Obstet. 2007;29(3):141-6.
31. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocr Rev. 1997;18(6):774-800.
32. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996;19(10):1138-41.
33. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57-63.
34. Geloneze B, Tambascia MA. Avaliação laboratorial e diagnóstico da resistência insulínica. Arq Bras Endocrinol Metab. 2006;50(2):208-15.
35. Acosta AM, Escalona M, Maiz A, Polelak F, Leighton F. Determination of the insulin resistance index by the homeostasis model assessment in a population of Metropolitan Region in Chile. Rev Med Chil. 2002;130(11):1227-31.
36. Kauffmann RP, Baker VM, DiMarino P, Gimpel T, Castracane V. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol. 2002;187(5):1362-9.
37. Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod. 2009;24(7):1726-31.
38. Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod. 2008;23(1):153-9.